Medicare Enrolled
Dr. Steven Eisenberg, D.O.
Hematology & Oncology · San Diego, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eisenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eisenberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eisenberg
Dr. Steven Eisenberg is a hematology & oncology specialist in San Diego, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Eisenberg performed 77,774 Medicare services across 2,374 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eisenberg received a total of $12,045 from 82 pharmaceutical and/or device companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eisenberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in CA
$12,045 industry payments
Medicare Practice Summary
Medicare Utilization ↗77,774
Medicare services
Top 10% in CA for hematology & oncology
2,374
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,889 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
47,500 | $2 | $12 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
15,750 | $1 | $9 |
| Denosumab injection (Prolia/Xgeva) | 6,360 | $18 | $51 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,800 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
950 | $7 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
944 | $8 | $11 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
608 | $10 | $27 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
602 | $69 | $286 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
544 | $93 | $418 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
458 | $0 | $8 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
317 | $11 | $40 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
139 | $13 | $35 |
| Iron level test | 131 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
131 | $8 | $22 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
118 | $1,475 | $4,963 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 115 | $285 | $898 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
104 | $9 | $24 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
98 | $26 | $87 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
96 | $6 | $16 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
96 | $118 | $400 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
92 | $30 | $90 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
84 | $52 | $248 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 82 | $20 | $53 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
61 | $58 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
60 | $1 | $9 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
56 | $16 | $41 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
50 | $14 | $38 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
47 | $26 | $84 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
46 | $1 | $10 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
45 | $74 | $306 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
43 | $1 | $2 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
42 | $60 | $154 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $43 | $174 |
| PSA test (prostate cancer screening) | 29 | $18 | $46 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
27 | $13 | $37 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
26 | $19 | $48 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
25 | $14 | $47 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $89 | $303 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $107 | $450 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
15 | $113 | $628 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.6% high complexity
73.1% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,045
Total received (2018-2024)
Avg $1,721/year across 7 years
Top 29% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
560
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,717 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$328 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,432
2023
$3,613
2022
$1,910
2021
$852
2020
$537
2019
$1,536
2018
$1,164
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$410
Novartis Pharmaceuticals Corporation
$268
Gilead Sciences, Inc.
$196
PFIZER INC.
$177
Celgene Corporation
$143
Janssen Biotech, Inc.
$136
Genmab U.S., Inc.
$123
Eisai Inc.
$117
AstraZeneca Pharmaceuticals LP
$97
GlaxoSmithKline, LLC.
$71
Bayer Healthcare Pharmaceuticals Inc.
$64
Daiichi Sankyo Inc.
$57
ABBVIE INC.
$56
Regeneron Healthcare Solutions, Inc.
$54
Verity Pharmaceuticals Inc.
$53
Aveo Pharmaceuticals, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$38
Merck Sharp & Dohme LLC
$28
BeiGene USA, Inc.
$28
PUMA BIOTECHNOLOGY, INC.
$27
ADC Therapeutics America, Inc.
$26
Genentech USA, Inc.
$24
Kite Pharma, Inc.
$21
SpringWorks Therapeutics, Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$19
Cardinal Health 414 LLC
$19
Incyte Corporation
$18
Exelixis Inc.
$17
ARRAY BIOPHARMA INC
$16
Octapharma USA, Inc.
$13
Fennec Pharmaceuticals, Inc.
$13
Top 3 companies account for 35.9% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$1,124
Novartis Pharmaceuticals Corporation
$1,089
E.R. Squibb & Sons, L.L.C.
$878
PFIZER INC.
$728
Gilead Sciences, Inc.
$711
Alexion Pharmaceuticals, Inc.
$468
Amgen Inc.
$382
Janssen Biotech, Inc.
$379
Pharmacyclics LLC, An AbbVie Company
$365
Coherus Biosciences Inc.
$343
Kite Pharma, Inc.
$260
AstraZeneca Pharmaceuticals LP
$252
Merck Sharp & Dohme Corporation
$242
GlaxoSmithKline, LLC.
$225
Seagen Inc.
$225
Merck Sharp & Dohme LLC
$224
BeiGene USA, Inc.
$213
Regeneron Healthcare Solutions, Inc.
$209
ARRAY BIOPHARMA INC
$195
Genentech USA, Inc.
$176
Pharmacyclics LLC, an AbbVie Company
$173
Daiichi Sankyo Inc.
$164
Exelixis Inc.
$159
Eisai Inc.
$145
Seattle Genetics, Inc.
$132
TerSera Therapeutics LLC
$125
Genmab U.S., Inc.
$123
Incyte Corporation
$111
Astellas Pharma US Inc
$109
Bayer Healthcare Pharmaceuticals Inc.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$94
ABBVIE INC.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Karyopharm Therapeutics Inc.
$88
ADC Therapeutics America, Inc.
$83
EMD Serono, Inc.
$73
Verity Pharmaceuticals Inc.
$72
Ipsen Biopharmaceuticals, Inc
$65
Octapharma USA, Inc.
$61
Fresenius Kabi USA, LLC
$59
Stemline Therapeutics Inc.
$57
Epizyme, Inc.,
$54
Sumitomo Pharma America, Inc.
$53
Lilly USA, LLC
$53
GENZYME CORPORATION
$52
SOBI, INC
$48
Foundation Medicine, Inc.
$45
AMAG Pharmaceuticals, Inc.
$45
Puma Biotechnology, Inc.
$45
Aveo Pharmaceuticals, Inc.
$42
SERVIER PHARMACEUTICALS LLC
$40
TOLMAR Pharmaceuticals, Inc.
$38
Teva Pharmaceuticals USA, Inc.
$35
AbbVie, Inc.
$34
Taiho Oncology, Inc.
$34
PharmaEssentia USA Corporation
$34
CTI BioPharma Corp.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
TESARO, Inc.
$28
PUMA BIOTECHNOLOGY, INC.
$27
MENARINI SILICON BIOSYSTEMS, INC.
$27
Acceleron Pharma, Inc.
$24
Myovant Sciences Inc.
$24
Pharmacosmos Therapeutics Inc.
$23
TAIHO ONCOLOGY, INC.
$22
Progenics Pharmaceuticals, Inc.
$22
EISAI INC.
$21
EUSA Pharma (US) LLC
$21
SpringWorks Therapeutics, Inc.
$21
ACCORD HEALTHCARE, INC.
$20
PROGENICS PHARMACEUTICALS, INC.
$19
Cardinal Health 414 LLC
$19
JAZZ PHARMACEUTICALS INC.
$18
Clovis Oncology, Inc.
$17
Acrotech Biopharma Inc.
$17
Partner Therapeutics, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Verastem, Inc.
$15
Array BioPharma Inc.
$14
INSYS Therapeutics Inc
$14
Mirati Therapeutics, Inc.
$13
Fennec Pharmaceuticals, Inc.
$13
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CYRAMZA · Cabometyx · Cellsearch · Columvi · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIGARD · EMPLICITI · ERLEADA · EXKIVITY · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · MEKINIST · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PYLARIFY · Padcev · Pedmark · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stimufend · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VOTRIENT · Vectibix · Venclexta · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YERVOY · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
130
Per 100K population
4.0
County median income
$102,285
Nearest hospital
AURORA SAN DIEGO
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eisenberg is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eisenberg experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Eisenberg performed 47,500 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eisenberg receive payments from pharmaceutical companies?
Yes. Dr. Eisenberg received a total of $12,045 from 82 companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eisenberg's costs compare to other hematology & oncology specialists in San Diego?
Dr. Eisenberg's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eisenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Diego
Browse hematology & oncology specialists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology